Searched for
GENERIC DRUGS COMPARISON
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...01 May, 2026, 11.01 PM IST- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...27 Apr, 2026, 10.33 AM IST
- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...13 Apr, 2026, 07.23 AM IST
- Sun Pharma shares tumble 4% as firm closes in on $12-billion Organon acquisition. What’s spooking investors?Shares of Sun Pharmaceutical Industries fell sharply after ET reported the company had submitted a $12-billion binding offer for Organon & ...10 Apr, 2026, 11.30 AM IST
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...10 Apr, 2026, 09.49 AM IST
- GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy genericsIndian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and...27 Mar, 2026, 02.22 PM IST
- Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahead?Pharma stocks rose up to 4% as Novo Nordisk’s semaglutide patent nears expiry, raising expectations of cheaper generics in India. Strong gr...20 Mar, 2026, 12.40 PM IST
- The weight is over. This injectable fits the billIndia's diabetes and weight-loss drug market is set for a major shift. Novo Nordisk's popular drug semaglutide is now off patent. Over 40 c...20 Mar, 2026, 08.09 AM IST
- Trump’s prescription drug price cuts unlikely to hit Indian pharma exports significantly: Crisil RatingsCrisil Ratings reports that President Trump's order to cut US drug prices will have a limited effect on Indian pharma. India's exports, mai...03 Jun, 2025, 04.33 PM IST
- Study links India-made generic drugs with 54 pc more severe adverse outcomes than US-made onesA new study reveals that generic drugs made in India are associated with 54 percent more severe adverse events, including hospitalisation a...20 Feb, 2025, 04.20 PM IST
- US leans on India's pharma industry to snub China. There's just one catchAmerica's reliance on China for drug ingredients has raised alarm bells in Congress. House committees will hold two hearings Tuesday on dru...06 Feb, 2024, 12.52 AM IST
- Pharma exports growth heading for a sharp decline: CrisilThe annual sales growth of generic drugs in the US, the largest generics market, is seen slowing to 8-9 per cent over the next five years, ...17 May, 2016, 08.27 PM IST
- Doctors: Patents keep HIV drugs too pricy to useDoctors Without Borders warned today that rising intellectual property rights are blocking the generic production of newer drugs to treat H...02 Jul, 2013, 10.41 PM IST
- Health Ministry pushes for end to sale of branded drugsAll pharmaceutical firms applying for licence to market or manufacture fixed dose combination (FDC) drugs will have to submit their generic...16 Oct, 2012, 07.49 AM IST
- Drug pricing by manufacturers, hospital retailers exploiting the consumerThe common man is pummelled by banking, insurance, real estate and other sectors, and by regulators. Health and pharma sectors can be added...26 Nov, 2011, 03.18 AM IST
- Govt wakes up to Branded Vs Generic drugs businessGovt has asked AIIMS to examine the efficacy of unbranded generic medicines sold in the country in comparison to their branded versions.26 Dec, 2008, 07.52 PM IST
- Merck Generics valuation to be hit as Duoneb patent endsMerck Generics' lucrative US subsidiary Dey, a specialty pharmaceutical company focused on the development of new drug delivery systems for...02 Mar, 2007, 12.43 AM IST
Load More
